PRODUCTION AND EFFECT OF INFECTIOUS DANE PARTICLES IN TRANSGENIC MICE

被引:9
作者
ARAKI, K
NISHIMURA, S
OCHIYA, T
OKUBO, K
MIYAZAKI, J
MATSUBARA, K
YAMAMURA, K
机构
[1] CHEMO-SERO-THERAPEUT RES INST,KIKUCHI LABS,KUMAMOTO 86115,JAPAN
[2] OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1991年 / 82卷 / 03期
关键词
TRANSGENIC MOUSE; DANE PARTICLE; DEVELOPMENTAL EXPRESSION;
D O I
10.1111/j.1349-7006.1991.tb01834.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have demonstrated by immunoelectron microscopy that 42-nm particles with double-shelled structures characteristic of Dane particles are present in the serum of transgenic mice, 1.2HB-BS 10, carrying partly duplicated hepatitis B virus (HBV) genome. Furthermore, these particles were shown to infect primary human fetal hepatocytes as demonstrated by the elevation of HBV surface antigen (HBsAg) in the culture medium. HBV DNA is known to be expressed in a liver- and kidney-specific manner in the adult mouse, so we examined the developmental expression of viral antigens. In the liver, viral antigens (HBsAg and HBV e antigen) began to be expressed before birth and the level of expression showed a sharp rise after birth. On the other hand, in the kidney, viral antigens began to be expressed after birth. Serum levels of viral antigens were roughly proportional to the levels of expression in the liver, suggesting that the liver is the main source for viral antigens in the serum. None of these transgenic mice produced anti-HBs or anti-HBV core response or showed biochemical or pathological change up to at least 24 months of age. All these results suggest that infectious viral particles can be produced in transgenic mice, and that expression and replication of HBV DNA are not toxic in vivo.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 18 条
[1]   EXPRESSION AND REPLICATION OF HEPATITIS-B VIRUS GENOME IN TRANSGENIC MICE [J].
ARAKI, K ;
MIYAZAKI, J ;
HINO, O ;
TOMITA, N ;
CHISAKA, O ;
MATSUBARA, K ;
YAMAMURA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :207-211
[2]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[3]  
2-J
[4]   TISSUE PREFERENTIAL EXPRESSION OF THE HEPATITIS-B VIRUS (HBV) SURFACE-ANTIGEN GENE IN 2 LINES OF HBV TRANSGENIC MICE [J].
BURK, RD ;
DELOIA, JA ;
ELAWADY, MK ;
GEARHART, JD .
JOURNAL OF VIROLOGY, 1988, 62 (02) :649-654
[5]   EXPERIMENTAL SYSTEMS FOR THE STUDY OF HEPADNAVIRUS AND HEPATITIS DELTA VIRUS-INFECTIONS [J].
MASON, WS ;
TAYLOR, JM .
HEPATOLOGY, 1989, 9 (04) :635-645
[6]  
MILICH DR, 1983, J IMMUNOL, V130, P1395
[7]  
MOIRYAMA T, 1990, SCIENCE, V248, P361
[8]   AN INVITRO SYSTEM FOR INFECTION WITH HEPATITIS-B VIRUS THAT USES PRIMARY HUMAN-FETAL HEPATOCYTES [J].
OCHIYA, T ;
TSURIMOTO, T ;
UEDA, K ;
OKUBO, K ;
SHIOZAWA, M ;
MATSUBARA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) :1875-1879
[9]   PRODUCTION OF HEPATITIS-B VIRUS-PARTICLES IN HEP-G2 CELLS TRANSFECTED WITH CLONED HEPATITIS-B VIRUS-DNA [J].
SELLS, MA ;
CHEN, ML ;
ACS, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (04) :1005-1009
[10]   A HUMAN HEPATITIS-B VIRAL ENHANCER ELEMENT [J].
SHAUL, Y ;
RUTTER, WJ ;
LAUB, O .
EMBO JOURNAL, 1985, 4 (02) :427-430